Trial Profile
A Retrospective Analysis of Mycophenolate (Cellcept) in Generalized Myasthenia Gravis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2017
Price :
$35
*
At a glance
- Drugs Mycophenolate (Primary)
- Indications Myasthenia gravis
- Focus Therapeutic Use
- 06 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology